Related Experiment Video
Updated: May 29, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Proteomic and transcriptomic analysis of linezolid resistance in Streptococcus pneumoniae
Jie Feng1, Dewan S Billal, Andréanne Lupien
1Centre de Recherche en Infectiologie and Plate-forme §Protéomique du Centre de génomique de Québec, Université Laval, CHUQ, Pavillon CHUL, 2705 boulevard Laurier, Quebec, QC, Canada, G1V 4G2.
Abstract:
Linezolid is an oxazolidinone antibiotic that inhibits the initiation of translation. Although resistance to linezolid is an uncommon event, it has been reported in clinical isolates. The genome sequence of Streptococcus pneumoniae linezolid-resistant mutants recently revealed mutations associated with resistance. A proteomic and transcriptomic screen now reveals a possible increase in the metabolism and transport of carbohydrates in these linezolid-resistant S. pneumoniae mutants. Several glycolytic proteins were shown to be overexpressed in the resistant strains, along with other enzymes and transporters involved in the metabolism of sugars. An increase in energy needs appears to be required to sustain extended levels of resistance to linezolid as the disruption of two ABC transporters putatively involved in the import of carbohydrates leads to a 2-fold sensitization to linezolid. Furthermore, the disruption of the catabolite control protein A, a regulator of the metabolism of sugars whose expression is highly increased in one linezolid-resistant mutant, resulted in a 2-fold increase in linezolid susceptibility. This global scale analysis of gene and protein expression profiling highlights metabolism alterations associated with linezolid resistance in S. pneumoniae.
Insights
Linezolid resistance in Streptococcus pneumoniae may involve increased carbohydrate metabolism and transport. Alterations in sugar metabolism proteins and transporters contribute to antibiotic resistance.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Linezolid is a crucial antibiotic for treating infections caused by Gram-positive bacteria.
- Resistance to linezolid, though uncommon, is an emerging clinical concern.
- Genetic mutations have been identified in linezolid-resistant Streptococcus pneumoniae.
Purpose of the Study:
- To investigate the molecular mechanisms underlying linezolid resistance in Streptococcus pneumoniae.
- To identify metabolic and transport pathways affected in resistant strains.
- To explore potential therapeutic targets for overcoming linezolid resistance.
Main Methods:
- Comparative genomics of linezolid-resistant mutants.
- Proteomic and transcriptomic analyses to profile gene and protein expression.
- Functional studies involving gene disruption of specific transporters and regulators.
Main Results:
- Linezolid-resistant S. pneumoniae mutants exhibit an upregulation of carbohydrate metabolism and transport proteins.
- Overexpression of glycolytic enzymes and sugar transporters was observed in resistant strains.
- Disruption of specific ABC transporters and catabolite control protein A increased linezolid susceptibility, indicating their role in resistance.
Conclusions:
- Metabolic alterations, particularly in carbohydrate processing, are significantly associated with linezolid resistance in S. pneumoniae.
- Targeting sugar metabolism and transport pathways could be a strategy to combat linezolid resistance.
- This study provides a global perspective on the molecular basis of antibiotic resistance in S. pneumoniae.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Atypical Pneumonia

